SureTrader Nadex Advertisement
Home > Boards > US Listed > Cannabis >

Americann Inc (ACAN)

Add ACAN Price Alert      Hide Sticky   Hide Intro
Moderator: ash111, captainscotty
Search This Board: 
Last Post: 2/22/2017 11:56:54 PM - Followers: 61 - Board type: Free - Posts Today: 0

Image result for americann inc


AmeriCann, Incorporated 

3200 Brighton Blvd.
Unit 114
Denver, CO 80216



We have a multi-market growth strategy with a current portfolio of over 1,000,000 sq. ft. of sustainable cannabis production infrastructure in development. We are a reporting, publicly listed company with the US stock symbol: ACAN on the OTCQX marketplace.

Image result for marijuana


AmeriCann, Inc. develops, owns and supports advanced medical cannabis cultivation and processing facilities nationwide. The Company has a multi-market portfolio of over 1,000,000 square feet of sustainable cannabis production infrastructure in various stages of development.

AmeriCann's team includes experts in traditional horticulture, lean manufacturing, medical research, facility construction, regulatory compliance, security, marijuana cultivation and genetics, extraction processes, and infused product development.
To support local businesses that seek to serve cannabis patients in their communities we initiated the AmeriCann Preferred Partner Program. Through this program we provide an essential set of resources including advance cultivation facilities, access to a team of experts and in certain cases, capital for our partner's businesses. In addition, AmeriCann's team has been instrumental in winning cannabis licenses in competitive application processes throughout the country. This support is designed to assist our Preferred Partners in newly regulated markets.

AmeriCann leases facilities to our Preferred Partners that are designed with AmeriCann's propriety cultivation and processing system called "Cannopy." AmeriCann developed Cannopy with experts from traditional horticulture, lean manufacturing, regulatory compliance and cannabis cultivation. Cannopy includes automation throughout the production life-cycle, customized workflow processes, monitoring and controls, and top-line security systems. Cannopy empowers Preferred Partners to consistently produce medical marijuana for patients at the lowest cost in the most efficient, compliant manner. We provide initial and on-going training, policies, practices and procedures to operate the state-of-the-art facilities.

The expanding cannabis industry requires extensive real estate to meet the growing needs of patients. AmeriCann utilizes a proven strategy for identifying, acquiring and developing real estate specifically suited for cannabis operations. AmeriCann assists our Preferred Partners with the identification, design, permitting, acquisition, development and operation of scalable infrastructure to cultivate and to dispense medical marijuana in regulated markets.

As an early market participant, the Company plans to leverage its leadership in a formative industry to establish a dominant position as the cannabis industry expands.

Image result for marijuana

ACAN Share Structure

Market Value: $8,564,965 a/o Dec. 18, 2015
Authorized: 100,000,000 a/o Sept. 30, 2015
Outstanding: 16.600,000 a/o September 30, 2015

Float: 5.4 Mil.  a/o  September 30, 2015

Image result for marijuana

      Image result for check this out

      ACAN News and Updates (More Updates Coming Soon!)

      Massachusetts Medical Cannabis Center

      Previously the Company entered into an agreement to purchase a 52.6 acre parcel of undeveloped land in Freetown, Massachusetts. The property is located approximately 47 miles southeast of Boston. The Company plans to develop the property as the Massachusetts Medical Cannabis Center "MMCC". Plans for the MMCC may include the construction of sustainable greenhouse cultivation, processing, and infused product facilities that will be leased or sold to Registered Marijuana Dispensaries under the Massachusetts Medical Marijuana Program.

      The Company paid the seller $100,000 upon the signing of the agreement which amount will be applied toward the purchase price of $4,000,000 at the closing. Pursuant to the original agreement the closing was to take place on or before June 1, 2015. On May 6, 2015, to address site considerations before finalizing the planned development, the agreement was amended to extend the closing date to September 1, 2015. On August 27, 2015, after addressing the site considerations, the agreement was amended to extend the closing date to October 30, 2015 to provide additional time for permitting. In connection with this amendment, the Company paid the seller an additional $100,000. On October 23, 2015, the Company made an additional payment of $100,000 to extend the closing date to December 29, 2015. All payments made by the Company to the seller ($300,000) will be applied to the purchase price. On November 6th, 2015 the Company filed a Site Plan Application to the Town of Freetown Planning Department. The Planning Board will review the MMCC project on November 24th, 2015.

      Source:  OTC Markets



    AmeriCann’s goal is to serve medical cannabis patients by providing state of the art facilities designed and built to produce high quality, consistent medicine that is cultivated and processed in a controlled, secure, and sustainable environment. Our belief in sustainable cultivation and processing practices — and our responsibility towards our community and environment — is driven by the core belief that every patient should have access to safe, regulated medical cannabis.



    Mr. Barton has been the managing director of a Colorado-based venture capital and private equity firm since 2006. He has extensive experience in the public and private capital markets, and has been instrumental in raising of over $800 million in equity and debt financing for emerging companies over the past decade. He earned an MBA in finance from UCLA.



    Mr. Keogh offers a unique combination of firsthand experience in the cannabis industry, from licensing to operations in numerous states, and an extensive background in real estate development. He is a director of one of fifteen Provisionally Registered marijuana dispensaries in Massachusetts, a board member of the Cannabis Producers Association of New England, and an active member and invited speaker for the National Cannabis Industry Association. He received a BS in business administration from Mount St. Mary’s College.



    AmeriCann’s management team has a track record of success with both private and public companies includes an unprecedented level of industry experience and depth.



    Mr. Forington is the Head of Breeding and Strain Development for 303 Seeds, a cannabis genetics and seed company based in Denver, Colorado. After several years of cannabis R&D focused on the psychoactive cannabinoid compound THC, Mr. Forington shifted his focus to non-psychoactive cannabinoids including CBD, CBG, CBC and CBN. His breeding work includes the highest lab tested cannabidiol (CBD) and cannabigerol (CBG) plant specimens known in the medical cannabis market and he has received several cannabis awards.



    Dr. Anderson has over 25 years’ experience in public health research design and ethics. He has been a leader in the review, funding, and commercialization of behavioral research and development, including tech-based applications for health promotion and disease prevention. Dr. Anderson was a Project Director at the National Cancer Institute (NCI;NIH) and is currently the & Human Subjects Protections Administrator for the Federally-authorized Health Media Lab Institutional Review Board (IRB) in Washington, DC. He received his Ph.D. and MPH at the University Of Minnesota School Of Public Health.



    Most recently Dr. Corr managed a technical team for Syngenta responsible for providing technical advice to greenhouse facilities throughout North America. In the past he has been a faculty member at the University of Tennessee specializing in controlled-environment horticulture. Later, at the Ball Horticultural Company, he managed a research greenhouse, directed research, had responsibility for international sales and was Director of New Crop Development. In his position with Valent Biosciences he introduced a new organically-certified plant growth regulator for grape production.



    Mr. Brait is a licensed attorney specializing exclusively in the legal cannabis industry since he received his law degree and has developed a through understand and knowledge of all aspects of the industry. He is the managing partner of the Denver-based Green Law Firm and a founder of the Cannabis Commodities Exchange in Colorado. He was a Distinguished Scholar at Southern Methodist University where he received his BBA in finance and BA in political science before receiving his law degree from the U. of Arizona.



    Dr. Havens specializes in plant medicine and product development, with almost a decade of experience designing extraction systems, end products, conducting product and process research and creating innovative strategies for the Cannabis industry. Dr. Havens brings twenty years in alternative medicine and supplements combined with advanced training in extraction and manufacturing technology. Dr. Havens experience includes the creation of patent pending new extraction technologies and product line development for health and wellness industries.






    Many of the best opportunities for success in the cannabis industry are in emerging markets. Getting established early in a newly regulated state could enable you to become a dominant player in your region. If you attempt to enter a market later in the licensing process, the prospects for your business may diminish significantly.

    At AmeriCann, we can help you identify the most promising markets and help you navigate and obtain a valuable license. Additionally, we can provide a comprehensive set of services and the capital to help you succeed once you obtain a license.



    AmeriCann, Inc. develops, owns and supports advanced medical cannabis facilities in multiple states. In an effort to advance the quality of medical cannabis and to promote greater access for patients, AmeriCann has initiated the AmeriCann Preferred Partner Program. We support local businesses that seek to serve cannabis patients in their communities.

    AmeriCann does not cultivate, process, distribute or sell cannabis. Rather, we assist local partners to obtain licenses, to cultivate medicine and to provide important medicine to patients. The company provides an essential set of resources including advanced cultivation facilities, access to a team of experts and, in certain cases, working capital for our partners’ businesses. If you would like to learn more about the AmeriCann Preferred Partner Program or apply for the program, please download the Fact Sheet and complete the Preferred Partner Program Questionnaire.



    Justin Anderson, managing partner of Nature’s Own Wellness Center: “The combination of services that AmeriCann provided our company – cannabis expertise in conjunction with significant capital, is unprecedented in this industry.”

    He added that, “Not only did AmeriCann provide a significant loan of $1,000,000 that will help us meet the growing needs of our patients, but we have ongoing access to the company’s team of experts. This has already helped us improve the efficiency of our operations.” Sept 2014



    AmeriCann partnered with Wellness Group Pharms prior to the submittal of WGP’s application in Illinois. Paul Montes, Managing Partner of WGP stated that, “Our affiliation with AmeriCann was instrumental in our success in being awarded one of the few cultivation licenses granted in an extremely competitive Illinois application process.”

    Mr. Montes added, “AmeriCann is delivering a level of expertise and resources that is unequaled in the industry. Our partnership is excellent because we share a commitment to provide the best medical marijuana possible to the patients in Illinois.” Feb 2015




    Our purpose is to fuel the growth of the medical cannabis industry and eliminate barriers for our partners to succeed. We see a world that shifts from prohibition to regulation so that all patients have access to safe, regulated medical cannabis.

    AmeriCann, Inc. is a registered, audited, publicly traded, and fully reporting company with corporate offices in Denver and Boston. The company is focused on bringing sustainability and efficiency to the design, construction and oversight of highly productive, energy efficient greenhouse cannabis cultivation and processing facilities.

    Image result for National Marijuana News

    Stay updated and connected with what is happening nationwide with marijuana!









  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ACAN News: AmeriCann Added to LD Micro Index and Proposed Cannabis ETF Emerging AgroSphere DENVER, CO / Accesswire / February 21, 2017 / 02/21/2017 02:41:24 PM
#725  Sticky Note I've watched AmeriCann and owned the stock since Irishtrader1 11/23/16 04:40:01 PM
#515  Sticky Note AMERICANN LAUNCHES “SOLANNA” LINE OF CANNABIS INFUSED PRODUCTS captainscotty 10/29/16 08:07:12 PM
#1183   very excited Fibanotch 02/22/17 11:56:53 PM
#1182   Boston University CEO Tim keogh jonjonw38 02/22/17 08:57:30 PM
#1181   and why haven't they updated their valuation on harpdog 02/22/17 08:52:51 PM
#1180   i'm glad you are all excited and making harpdog 02/22/17 08:48:07 PM
#1179   I take 50 Fibanotch 02/22/17 10:39:41 AM
#1178   Could be a $100 stock someday Trons 02/22/17 08:48:09 AM
#1177   Congressional CannAbis Causus emit 02/22/17 01:45:17 AM
#1176   Glad i added again $2s!! doebop 02/22/17 12:55:45 AM
#1175   $5.42 !! "AmeriCann is included in the proposed jonjonw38 02/21/17 07:10:18 PM
#1174   Where's tarbol hes Been waiting for 50 cents still brandao 02/21/17 06:06:36 PM
#1173   Wow what happened here brandao 02/21/17 05:40:27 PM
#1172   #ACAN: Resuming the epic rise..:-} 30% green captainscotty 02/21/17 05:00:20 PM
#1171   $5.10. Massive blue sky ahead. See axim Trons 02/21/17 03:38:52 PM
#1170   Is anybody listening here? We are going over Trons 02/21/17 03:35:21 PM
#1169 Irishtrader1 02/21/17 01:40:44 PM
#1168   About to fly Trons 02/21/17 10:30:12 AM
#1167   Massachusetts Marijuana Panel Could Make Major Changes to mc67 02/19/17 08:52:42 AM
#1166 Irishtrader1 02/16/17 12:26:32 PM
#1165   I just bought more. I like how the emit 02/15/17 04:09:24 PM
#1164   Anyone who is serious about knowing more about Irishtrader1 02/15/17 12:03:24 PM
#1163 Irishtrader1 02/14/17 12:34:46 PM
#1162   Mass. getting ready to explode but without ACAN! tarballmonger 02/14/17 10:10:58 AM
#1161   You still don't know what ACAN does. They tarballmonger 02/14/17 09:52:45 AM
#1160   I agree with that 100%. To stay pauly3 02/14/17 09:07:21 AM
#1159   $ACAN After the buildings are up they should mc67 02/13/17 06:28:29 PM
#1158   When this baby does go she'll go fast emit 02/13/17 03:25:58 PM
#1157   $1.3 billion MJ Sales in Colorado! 2015 jonjonw38 02/11/17 03:26:24 PM
#1156   Of course. How else could it possibly come? tarballmonger 02/08/17 03:44:28 PM
#1155   Yes, I think you're right.. I'm waiting till mc67 02/08/17 03:31:55 PM
#1154   Has ACAN applied for construction permits so they tarballmonger 02/08/17 02:59:20 PM
#1153   Same deal here bud. I even sold Trons 02/08/17 10:45:55 AM
#1152   Does anyone know if Tim Keogh's speech at Minty157 02/08/17 09:27:49 AM
#1151 Irishtrader1 02/07/17 08:31:14 PM
#1150   Tim Keogh the CEO of Americann (ACAN) is Irishtrader1 02/07/17 08:08:19 PM
#1149   $ACAN... next stop $5. Irishtrader1 02/06/17 12:22:48 PM
#1148   Although I own stock here I'm pissed man brandao 02/06/17 10:25:49 AM
#1147   ACAN LETS GOOOO WOOO! LETS SEE 5$ bettfred15 02/03/17 11:30:22 AM
#1146   $4.48 $ACAN jjr04001 02/03/17 11:10:56 AM
#1145   I'm thinking ACAN will see $5 this week, Irishtrader1 02/01/17 03:43:21 PM
#1144   Once ACAN gets through $5 it looks like Stock dude 1 02/01/17 12:04:12 PM
#1143   I think we see a new high today. $ACAN Irishtrader1 02/01/17 12:03:56 PM
#1142   $4.44 $ACAN jjr04001 02/01/17 11:19:09 AM
#1141   $$$$$$$$$$$$ Trons 02/01/17 10:37:56 AM
#1140   $4.33 $ACAN jjr04001 02/01/17 10:16:08 AM
#1139   This is a new report from Oracle-a respected Irishtrader1 02/01/17 09:43:12 AM
#1138   AmeriCann Morningstar Jan 24 2017.pdf ? Irishtrader1 01/31/17 03:04:15 PM
#1137   "sustainable greenhouse cultivation, processing, and infused product facilities Trons 01/31/17 11:48:32 AM
#1136   $5 coming Trons 01/31/17 11:47:38 AM
#1135   Right now it doesn't brandao 01/31/17 09:57:59 AM
#1134   how does this company make money? BullsRun2002 01/31/17 09:33:43 AM